Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report)’s share price traded down 6.1% on Thursday . The stock traded as low as $2.74 and last traded at $2.75. 400,194 shares traded hands during trading, a decline of 63% from the average session volume of 1,080,999 shares. The stock had previously closed at $2.93. Analyst Ratings […]
Frazier Life Sciences Management L.P. lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 214.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,667,203 shares of the company’s stock after buying an additional 1,818,181 shares during the […]
Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report)’s share price traded down 6.1% on Thursday . The stock traded as low as $2.74 and last traded at $2.75. 400,194 shares traded hands during trading, a decline of 63% from the average session volume of 1,080,999 shares. The stock had previously closed at $2.93. Analyst Ratings […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) CEO Jeffrey Stein bought 8,000 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The stock was purchased at an average cost of $13.21 per share, with a total value of $105,680.00. Following the acquisition, the chief executive officer now directly owns […]
BlackBarn Capital Partners LP bought a new position in Diversified Healthcare Trust (NASDAQ:DHC – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,200,000 shares of the real estate investment trust’s stock, valued at approximately $4,488,000. Diversified Healthcare Trust […]